Crossmark

A systematic comparison of different composite measures (DAS 28, CDAI, SDAI, and Boolean approach) for determining treatment effects on low disease activity and remission in rheumatoid arthritis

Crossref DOI link: https://doi.org/10.1186/s41927-022-00314-7

Published Online: 2022-12-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Janke, Kirsten

Kiefer, Corinna

McGauran, Natalie

Richter, Bernd

Krause, Dietmar

Wieseler, Beate
Funding

Funding for this research was provided by:

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
License Information

Text and Data Mining valid from 2022-12-09

Version of Record valid from 2022-12-09
More Information

Article History

Received: 2 June 2022

Accepted: 7 October 2022

First Online: 9 December 2022

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below